Related Experiment Video
Updated: Jul 17, 2026
11:12
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
Published on: August 1, 2018
Gene-expression analysis and the basal-like breast cancer subtype
Timothy J Finnegan1, Lisa A Carey
1The University of North Carolina, Division of Hematology/Oncology, CB#7305, 3009 Old Clinic Building, Chapel Hill, NC 27599, USA. tfinnega@unch.unc.edu
Future Oncology (London, England)
|February 7, 2007
Summary
Breast cancer comprises distinct subtypes based on gene expression. This review focuses on the basal-like subtype, its characteristics, and treatment options.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Breast cancer is not a single disease but consists of biologically distinct subtypes.
- Molecular profiles reveal differences between estrogen receptor (ER)-positive and ER-negative breast cancers.
- Subtypes include basal-like, HER2/ER, luminal A, and luminal B.
Purpose of the Study:
- To review the molecular profiles of breast cancer subtypes.
- To focus on the clinical characteristics and treatment options for the basal-like subtype.
Main Methods:
- Analysis of gene expression patterns in breast cancer.
- Characterization of molecular profiles for different breast cancer subtypes.
- Review of clinical data and treatment strategies.
Main Results:
- Identified distinct molecular profiles for various breast cancer subtypes.
- Basal-like subtype shows low expression of ER-related and HER2-related genes.
- Basal-like subtype is often 'triple negative' in clinical assays.
Conclusions:
- Gene expression analysis refines breast cancer classification beyond ER status.
- Understanding molecular subtypes is crucial for targeted therapies.
- Further research into basal-like breast cancer is needed for improved treatment outcomes.